ENT Department, Guy's and St Thomas' NHS Trust, London, UK.
Am J Rhinol Allergy. 2023 Mar;37(2):232-239. doi: 10.1177/19458924231154070.
Heterogeneity in outcomes used in clinical trials prevents meta-analysis and contributes to research waste. Core outcome sets aim to address this by defining a small number of essential outcomes that should be measured in all effectiveness trials. Adoption in routine clinical practice can further improve outcomes for patients.There has been a rapid growth in therapeutic options available for patients with chronic rhinosinusitis with nasal polyps, but difficulty comparing results leads to uncertainty into optimum management, and there is a need to define a core outcome set. We consider whether work already undertaken needs to be modified for patients with nasal polyps.We recommend that a core outcome set should include assessment of disease specific quality of life, nasal polyp score, evaluation of sense of smell, alongside need for OCS and surgical treatment and complications from the disease or treatment. Further work is required to achieve international consensus regarding the choice of nasal polyp scoring system.
临床试验中使用的结果存在异质性,这使得荟萃分析变得困难,并导致了研究浪费。核心结局集旨在通过定义少数应在所有有效性试验中测量的基本结局来解决这个问题。在常规临床实践中的采用可以进一步改善患者的结局。
对于患有鼻息肉的慢性鼻-鼻窦炎患者,可供选择的治疗方法迅速增加,但由于难以比较结果,导致对最佳治疗方法的不确定性,因此需要定义一个核心结局集。我们考虑已经为鼻息肉患者开展的工作是否需要修改。
我们建议核心结局集应包括对疾病特异性生活质量、鼻息肉评分、嗅觉评估的评估,以及对 OCS 的需求、手术治疗和疾病或治疗的并发症。需要进一步开展工作以就鼻息肉评分系统的选择达成国际共识。